The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics.
作者信息
Gottesman O, Scott S A, Ellis S B, Overby C L, Ludtke A, Hulot J-S, Hall J, Chatani K, Myers K, Kannry J L, Bottinger E P
机构信息
The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
出版信息
Clin Pharmacol Ther. 2013 Aug;94(2):214-7. doi: 10.1038/clpt.2013.72. Epub 2013 Apr 3.
Abstract
摘要
相似文献
1
The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics.CLIPMERGE药物基因组学项目：通过电子健康记录以及基因组学-药物基因组学实现个性化医疗的临床应用
Clin Pharmacol Ther. 2013 Aug;94(2):214-7. doi: 10.1038/clpt.2013.72. Epub 2013 Apr 3.
2
Pharmacogenomics in Practice.实践中的药物基因组学
Clin Pharmacol Ther. 2019 Nov;106(5):936-938. doi: 10.1002/cpt.1600. Epub 2019 Sep 9.
3
Healthcare provider education to support integration of pharmacogenomics in practice: the eMERGE Network experience.医疗服务提供者教育以支持药物基因组学在实践中的整合：eMERGE 网络的经验。
Pharmacogenomics. 2017 Jul;18(10):1013-1025. doi: 10.2217/pgs-2017-0038. Epub 2017 Jun 22.
4
Challenges in implementing genomic medicine: the Mayo Clinic Center for Individualized Medicine.实施基因组医学面临的挑战：梅奥诊所个体化医学中心。
Clin Pharmacol Ther. 2013 Aug;94(2):204-6. doi: 10.1038/clpt.2013.52. Epub 2013 Mar 11.
5
Integrating pharmacogenomics into the electronic health record by implementing genomic indicators.通过实施基因组指标，将药物基因组学整合到电子健康记录中。
J Am Med Inform Assoc. 2020 Jan 1;27(1):154-158. doi: 10.1093/jamia/ocz177.
6
Building an information system to facilitate pharmacogenomics clinical translation with clinical decision support.建立一个信息系统，通过临床决策支持来促进临床转化。
Pharmacogenomics. 2022 Jan;23(1):35-48. doi: 10.2217/pgs-2021-0110. Epub 2021 Nov 17.
7
Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.电子病历整合的药物基因组学及相关临床决策支持概念
Clin Pharmacol Ther. 2017 Aug;102(2):254-264. doi: 10.1002/cpt.707. Epub 2017 May 26.
8
An ancillary genomics system to support the return of pharmacogenomic results.支持药代基因组学结果回报的辅助基因组学系统。
J Am Med Inform Assoc. 2019 Apr 1;26(4):306-310. doi: 10.1093/jamia/ocy187.
9
Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.个体化医学的预先基因分型：利用基因组数据制定正确的药物、正确的剂量、正确的治疗方案以实现个体化治疗。
Mayo Clin Proc. 2014 Jan;89(1):25-33. doi: 10.1016/j.mayocp.2013.10.021.
引用本文的文献
1
Key informant perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care in Ontario, Canada: a qualitative description study.加拿大安大略省基层医疗中抗抑郁药物处方的药物基因组学（PGx）检测的关键信息提供者观点：一项定性描述研究
BMJ Open. 2025 Aug 27;15(8):e091562. doi: 10.1136/bmjopen-2024-091562.
2
A feasibility study on implementing pre-emptive pharmacogenomics testing in outpatient clinics in Singapore (IMPT study).一项关于在新加坡门诊诊所实施先发制药物基因组学检测的可行性研究（IMPT研究）。
Pharmacogenomics J. 2025 Mar 12;25(1-2):7. doi: 10.1038/s41397-025-00366-1.
3
Pharmacogenomics and Big Data in medical oncology: developments and challenges.肿瘤医学中的药物基因组学与大数据：进展与挑战
Ther Adv Med Oncol. 2024 Oct 18;16:17588359241287658. doi: 10.1177/17588359241287658. eCollection 2024.
4
Receptor Pharmacogenomics: Deciphering Genetic Influence on Drug Response.受体药理学基因组学：解析遗传对药物反应的影响。
Int J Mol Sci. 2024 Aug 29;25(17):9371. doi: 10.3390/ijms25179371.
5
A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer.一项关于生殖系药物基因组学对成年癌症患者严重毒性和症状负担影响的系统评价和荟萃分析。
Clin Transl Sci. 2024 May;17(5):e13781. doi: 10.1111/cts.13781.
6
Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives.在卡塔尔开创精准医学之路：从公共卫生角度看药物基因组学计划。
Front Public Health. 2024 Mar 14;12:1364221. doi: 10.3389/fpubh.2024.1364221. eCollection 2024.
7
Moving towards the implementation of pharmacogenetic testing in Quebec.迈向魁北克药物遗传学检测的实施。
Front Genet. 2024 Jan 3;14:1295963. doi: 10.3389/fgene.2023.1295963. eCollection 2023.
8
Pharmacogenomic knowledge and awareness among diverse patients treated with angiotensin converting enzyme inhibitors.不同接受血管紧张素转换酶抑制剂治疗的患者的药物基因组学知识和认识。
Pharmacogenomics. 2023 Dec;24(18):921-930. doi: 10.2217/pgs-2023-0191. Epub 2023 Dec 6.
9
Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?临床实践中药基因组学检测预测试验的实施：我们目前的进展如何？
Br J Clin Pharmacol. 2025 Feb;91(2):270-282. doi: 10.1111/bcp.15956. Epub 2023 Dec 21.
10
Identification of Drugs Acting as Perpetrators in Common Drug Interactions in a Cohort of Geriatric Patients from Southern Italy and Analysis of the Gene Polymorphisms That Affect Their Interacting Potential.意大利南部老年患者队列中常见药物相互作用中作为肇事者的药物鉴定以及影响其相互作用潜力的基因多态性分析。
Geriatrics (Basel). 2023 Aug 24;8(5):84. doi: 10.3390/geriatrics8050084.
本文引用的文献
1
Personalizing medicine with clinical pharmacogenetics.临床药物遗传学个性化医疗。
Genet Med. 2011 Dec;13(12):987-95. doi: 10.1097/GIM.0b013e318238b38c.
2
Pharmacogenomics: "noninferiority" is sufficient for initial implementation.药物基因组学：“非劣效性”足以进行初步实施。
Clin Pharmacol Ther. 2011 Mar;89(3):348-50. doi: 10.1038/clpt.2010.310.
3
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.CPIC：药物基因组学研究网络临床药物基因组学实施联盟。
Clin Pharmacol Ther. 2011 Mar;89(3):464-7. doi: 10.1038/clpt.2010.279. Epub 2011 Jan 26.
4
A roadmap for national action on clinical decision support.国家临床决策支持行动路线图。
J Am Med Inform Assoc. 2007 Mar-Apr;14(2):141-5. doi: 10.1197/jamia.M2334. Epub 2007 Jan 9.
Zotero 插件